GlassScriptPhysician profile
Vincent Savarese
NPI 1033325444
$2,484.18
in general payments reported to CMS, 2019-2025
41 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $285 · 2021: $269 · 2022: $295 · 2023: $242 · 2024: $364 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $475.62 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Dexcom, INC. | $345.79 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $218.07 | 2019-2025 | Freestyle Libre 3, Freestyle Libre |
| Sanofi-Aventis U.S. LLC | $179.55 | 2019-2024 | |
| Lilly USA, LLC | $160.83 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $83.94 | 2021-2023 | |
| Antares Pharma, INC. | $78.96 | 2022-2025 | Xyosted |
| Insulet Corporation | $76.77 | 2019-2025 | Omnipod |
| Abbvie INC. | $65.38 | 2019-2025 | |
| Medtronic, INC. | $61.45 | 2021-2025 | Minimed 780g |
| Corcept Therapeutics | $51.72 | 2019-2025 | Korlym |
| Amneal Pharmaceuticals LLC | $47.64 | 2021-2024 | Unithroid |
| Lifescan, INC. | $43.83 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $42.76 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $39.75 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Savarese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.